---
figid: PMC7821222__FSB2-35-na-g007
figtitle: TNF‐A‐JNK‐RUNX1 pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC7821222
filename: FSB2-35-na-g007.jpg
figlink: pmc/articles/PMC7821222/figure/fsb221155-fig-0007/
number: F7
caption: TNF‐α‐JNK‐RUNX1 pathway. A, Schematic indicating the potential of a combined
  anti‐VEGF/anti‐RUNX1 therapy on the treatment of pathologic angiogenesis, (B, Schematic
  of the basic TNF‐α‐JNK‐RUNX1 pathway, including the actions of d‐glucose and anisomycin
  on JNK and the actions of named inhibitors, which have been identified as causing
  changes in RUNX1 expression levels
papertitle: TNF‐α signaling regulates RUNX1 function in endothelial cells.
reftext: Hannah A. B. Whitmore, et al. FASEB J. 2021 Feb;35(2):e21155.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.88485
figid_alias: PMC7821222__F7
figtype: Figure
redirect_from: /figures/PMC7821222__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7821222__FSB2-35-na-g007.html
  '@type': Dataset
  description: TNF‐α‐JNK‐RUNX1 pathway. A, Schematic indicating the potential of a
    combined anti‐VEGF/anti‐RUNX1 therapy on the treatment of pathologic angiogenesis,
    (B, Schematic of the basic TNF‐α‐JNK‐RUNX1 pathway, including the actions of d‐glucose
    and anisomycin on JNK and the actions of named inhibitors, which have been identified
    as causing changes in RUNX1 expression levels
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - TNF
  - RUNX1
  - TNFRSF1A
  - AN
  - MAPK8
  - MAPK9
  - MAPK10
  - TCOF1
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - Glucose
  - Anisomycin
  - Ro5-3335
  - TCS
  - Al
  - Withaferin A
  - Glucose - Glucose
---
